Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
journal contribution
posted on 2024-05-09, 14:41 authored by COVIDSurg Collaborative, J De Marchi, Arnold HillArnold Hill, T Farrell, NF Davis, D Kearney, T Nelson, Dara KavanaghDara KavanaghThere is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.
Funding
National Institute for Health Research (NIHR) Global Health Research Unit grant (NIHR 16.136.79) using UK aid from the UK government to support global health research
Association of Coloproctology of Great Britain and Ireland
Bowel & Cancer Research
Bowel Disease Research Foundation
Association of Upper Gastrointestinal Surgeons
British Gynaecological Cancer Society
European Society of Coloproctology
NIHR Academy
Sarcoma UK
The Urology Foundation
Vascular Society for Great Britain and Ireland
Yorkshire Cancer Research
British Association of Surgical Oncology
History
Comments
The original article is available at https://academic.oup.com/Published Citation
COVID Surg Collaborative. Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection. BJS Open. 2021;5(6):zrab131Publication Date
8 January 2022External DOI
PubMed ID
35022673Department/Unit
- Beaumont Hospital
- Surgery
- Surgical Affairs
Research Area
- Gynaecology, Obstetrics and Perinatal Health
- Surgical Science and Practice
- Cancer
Publisher
Oxford University Press (OUP)Version
- Published Version (Version of Record)
